Skip to main content

Find Clinical Trials

Home
Conditions
Agranulocytosis

Clinical trial condition

Agranulocytosis

Explore clinical trials studying Agranulocytosis. Study availability and eligibility vary by location and protocol.

294 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Agranulocytosis trial results

Completed

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

NCT00174473

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

NCT00497809

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations: Pacific Cancer Medical Center Anaheim, California, United States

California Cancer Center Greenbrae, California, United States

Ghassan Al-Jazayrly, MD, Inc. Los Angeles, California, United States

Desert Hematology Oncology Medical Group Rancho Mirage, California, United States

View all 31 locations

View Trial Details

Completed

Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

NCT01086878

Conditions: Acquired Immunodeficiency Syndrome, Agranulocytosis, Anemia, +22 more
Locations: Princess Marina Hospital Gaborone, Botswana

Scottish Livingstone Hospital Molepolole, Kweneng District, Botswana

View Trial Details

Completed

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

NCT01285219

Conditions: Agranulocytosis, Cancer, Cytopenia, +6 more
Locations: Not specified

View Trial Details

Completed

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

NCT00125723

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

NCT00277160

Conditions: Adnexal Diseases, Agranulocytosis, Breast Cancer, +39 more
Locations: Not specified

View Trial Details

Completed

Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia

NCT00723073

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

NCT00008840

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations: Mary Ellen Bradley Birmingham, Alabama, United States

View Trial Details

Completed

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma

NCT00794261

Conditions: Agranulocytosis, Blood Platelet Disorders, Cytopenia, +16 more
Locations: CHU Angers Angers, France

CHU Brest Brest, France

Centre Leon Berard Lyon, France

Hopital Edouard Herriot Lyon, France

View Trial Details

Completed

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

NCT00035620

Conditions: Agranulocytosis, Bone Diseases, Bone Neoplasms, +12 more
Locations: Not specified

View Trial Details